Triethylene Melamine Therapy in Hodgkin's and other Malignant Diseases

Burchenal J. H. Johnston S. F. Cremer M. Webber I. F. Stock C. C. : The action of certain ethylenimine (Aziridine) derivatives on mouse leukemia. Arch. Biochem. 26 (1950), 321.

Burchenal J. H. Johnston S. F. Stock C. C. Crossley M. L. Rhoads C. P. : The effect of 2, 4, 6-triethyleneimino-s-triazine and related compounds on transplanted mouse leukemia. Cancer Research 10 (1950), 208.

Karnofsky D. A. Burchenal J. H. Armistead G. C. Jr. Southam C. M. Bernstein J. L. Craver L. F. Rhoads C. P. : Triethylene melamine in the treatment of neoplastic disease. Arch. Int. Med. 87 (1951), 477.

Lewis M. R. Crossley M. L. : Retardation of tumor growth in mice by oral administration of ethylenimine derivatives. Arch. Biochem. 26 (1950), 319.

Paterson Edith Boland J. : Trisethyleneimino-s-triazine in human malignant disease: A preliminary trial. Brit. J. Cancer 5 (1951), 28.

Philips F. S. Thiersch J. B. : The nitrogen mustard-like actions of certain ethylenimines: I 2, 4, 6-tris (ethylenimino)-S-triazine and analogs. J. Pharmacol. & Exper. Therap. 100 (1950), 398.

Rhoads C. P. Karnofsky D. A. Burchenal J. H. Craver L. F. : Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms. Tr. A. Am. Physicians 63 (1950), 136. (Atlantic City, May 2. 1950.)

Rose F. L. Hendry J. A. Walpole A. L. : New cytotoxic agents with tumourinhibitory activity. Nature 165 (1950), 993.

Wright L. T. Wright Jane C. Prigot Aa. Weintraub S. : Triethylene melamine therapy in Hodgkin's disease and allied neoplastic diseases. J. Nat. M.A. 42 (1950), 343.